MEDSURGE ALFENTANIL alfentanil (as hydrochloride) 5 mg/10 mL solution for injection ampoule Australien - engelska - Department of Health (Therapeutic Goods Administration)

medsurge alfentanil alfentanil (as hydrochloride) 5 mg/10 ml solution for injection ampoule

medsurge pharma pty ltd - alfentanil hydrochloride, quantity: 5.44 mg (equivalent: alfentanil, qty 5 mg) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; sodium chloride - alfentanil injection is indicated for intravenous use by specialist anaesthetists and their trainees as:,? an analgesic supplement given by incremental intravenous boluses or continuous infusion; and,? an anaesthetic induction agent where in patients undergoing in-patient surgery, when endotracheal intubation and controlled ventilation are to be used.,because of its rapid onset and short duration of action, intravenous alfentanil (as hydrochloride) is particularly suited as a narcotic analgesic for short procedures and outpatients, provided that the patients are maintained under appropriate post-operative surveillance. however, intravenous alfentanil (as hydrochloride) is also useful as an analgesic supplement for procedures of medium to long duration, since periods of very painful stimuli can be easily overcome by administration of small increments of alfentanil (as hydrochloride) or by adapting the infusion rate.

MEDSURGE ALFENTANIL alfentanil (as hydrochloride) 1 mg/2 mL solution for injection ampoule Australien - engelska - Department of Health (Therapeutic Goods Administration)

medsurge alfentanil alfentanil (as hydrochloride) 1 mg/2 ml solution for injection ampoule

medsurge pharma pty ltd - alfentanil hydrochloride, quantity: 1.09 mg (equivalent: alfentanil, qty 1 mg) - injection, solution - excipient ingredients: sodium hydroxide; water for injections; sodium chloride - alfentanil injection is indicated for intravenous use by specialist anaesthetists and their trainees as:,? an analgesic supplement given by incremental intravenous boluses or continuous infusion; and,? an anaesthetic induction agent where in patients undergoing in-patient surgery, when endotracheal intubation and controlled ventilation are to be used.,because of its rapid onset and short duration of action, intravenous alfentanil (as hydrochloride) is particularly suited as a narcotic analgesic for short procedures and outpatients, provided that the patients are maintained under appropriate post-operative surveillance. however, intravenous alfentanil (as hydrochloride) is also useful as an analgesic supplement for procedures of medium to long duration, since periods of very painful stimuli can be easily overcome by administration of small increments of alfentanil (as hydrochloride) or by adapting the infusion rate.

Alfentanil Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

alfentanil

medsurge pharma limited - alfentanil hydrochloride 0.544 mg/ml equivalent to alfentanil 0.5mg/ml - solution for injection - 1 mg/2ml - active: alfentanil hydrochloride 0.544 mg/ml equivalent to alfentanil 0.5mg/ml excipient: sodium chloride sodium hydroxide water for injection - alfentanil injection is indicated in adults and children aged above one year for use as: · an opioid analgesic in general or regional anaesthesia for both short (bolus injections) and long (bolus, supplemented by increments or by continuous infusion) surgical procedures. · an anaesthetic induction agent. due to its rapid and short-lasting action, alfentanil injection is particularly suited as an opioid analgesic for short procedures and outpatient surgery. it is also useful as an analgesic supplement for procedures of medium and long duration, since periods of very painful stimuli can easily be overcome by small increments of alfentanil injection or by adapting its infusion rate.

Alfentanil Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

alfentanil

medsurge pharma limited - alfentanil hydrochloride 0.544 mg/ml equivalent to alfentanil 0.5mg/ml - solution for injection - 5 mg/10ml - active: alfentanil hydrochloride 0.544 mg/ml equivalent to alfentanil 0.5mg/ml excipient: sodium chloride sodium hydroxide water for injection - alfentanil injection is indicated in adults and children aged above one year for use as: · an opioid analgesic in general or regional anaesthesia for both short (bolus injections) and long (bolus, supplemented by increments or by continuous infusion) surgical procedures. · an anaesthetic induction agent. due to its rapid and short-lasting action, alfentanil injection is particularly suited as an opioid analgesic for short procedures and outpatient surgery. it is also useful as an analgesic supplement for procedures of medium and long duration, since periods of very painful stimuli can easily be overcome by small increments of alfentanil injection or by adapting its infusion rate.

REMIFENTANIL FOR INJECTION POWDER FOR SOLUTION Kanada - engelska - Health Canada

remifentanil for injection powder for solution

sandoz canada incorporated - remifentanil (remifentanil hydrochloride) - powder for solution - 1mg - remifentanil (remifentanil hydrochloride) 1mg - opiate agonists

REMIFENTANIL FOR INJECTION POWDER FOR SOLUTION Kanada - engelska - Health Canada

remifentanil for injection powder for solution

sandoz canada incorporated - remifentanil (remifentanil hydrochloride) - powder for solution - 2mg - remifentanil (remifentanil hydrochloride) 2mg - opiate agonists

VORICONAZOLE WOCKHARDT voriconazole 200 mg powder for injection vial Australien - engelska - Department of Health (Therapeutic Goods Administration)

voriconazole wockhardt voriconazole 200 mg powder for injection vial

wockhardt bio pty ltd - voriconazole, quantity: 200 mg - injection, powder for - excipient ingredients: sodium chloride; hydroxypropylbetadex - voriconazole wockhardt is indicated for treatment of the following fungal infections:,invasive aspergillosis.,serious candida infections (including c. krusei), including systemic candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia).,serious fungal infections caused by scedosporium spp and fusarium spp.,other serious fungal infections, in patients intolerant of, or refractory to, other therapy.,prophylaxis in patients who are at high risk of developing invasive fungal infections. the indication is based on studies including patients undergoing haematopoietic stem cell transplantation.